May 22, 2024 · Form 4 insider transaction
SACHS BRUCE I sold 7,073 shares of Vertex Pharmaceuticals Incorporated at $448.00 per share, a transaction worth $3.17M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1, which was entered into on 02/12/2024.